Quinapril Hydrochloride

盐酸喹那普利

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameQuinapril Hydrochloride
Drug Alias Name奎那普利盐酸盐Accuzidequinaprilum喹那普利盐酸盐盐酸奎那普利 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsHypertensionHeart Failure
Approved Indications in ChinaHypertensionHeart Failure
Original Approved Country/TerritoryUnited States
Original Approved Date1991/11/19
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Co Ltd General Pharm Factory
Inactive CompaniesMylan Pharmaceuticals IncPfizer Pharmaceuticals Llc
Active IndicationsHypertensionHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC09AA06
Related LinksWikipediaDrugBankKEGG